Recently, different authors have studied hepcidin levels in the blood of IBD patients to verify its potential as a noninvasive biomarker able to connect inflammation and iron metabolism, especially in the presence of anemia [18,19,20,21,22,23,24,25,26,27,28,29]. This evidence concerns the gene HAMP and inflammatory bowel disease.